Wordt geladen...
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
BACKGROUND: The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55–69. Knowing how the potential benefits and harms of screening vary by an individual’s risk of developing prostate cancer could infor...
Bewaard in:
| Gepubliceerd in: | PLoS Med |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924639/ https://ncbi.nlm.nih.gov/pubmed/31860675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002998 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|